Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Lamtor5–ESCRT–cGAS Macrophage Immunosenescence Axis

Current understanding

Age-dependent decline of Lamtor5 (LAMTOR5/HBXIP), a Ragulator complex component, is proposed to impair ESCRT-mediated lysosomal degradation of cytosolic cGAS in macrophages, allowing cGAS accumulation and paracrine cGAS–STING-driven inflammation that spreads immunosenescence and drives systemic aging phenotypes [animal-model]. In mouse models, macrophage-restricted cGAS blockade (siRNA/peptide), young-macrophage transplant, or senolytic treatment reportedly rescue tissue aging endpoints [animal-model]. Translation to humans is untested and the axis has not been shown to modify human lifespan or healthspan.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.
16-jul-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18